Occult Breast Cancer Presented with Axillary Lymph Node Metastases: A Small Case Series to a Frustrating Medical Issue
Tóm tắt
Occult breast carcinoma (OBC) presenting with axillary metastases and no identifiable breast tumor is a rare entity that can be a diagnostic and therapeutic challenge. Retrospectively, we gathered data from five female patients who presented to us with enlarged axillary nodes. Data collected included age at diagnosis, presenting complaints, imaging studies, surgical findings, histology, treatment, and progress. All patients underwent mammographic examination as well as breast ultrasound with no evidence of disease. In all five cases, there was a positive preoperative biopsy of the affected lymph node for breast adenocarcinoma. All patients were treated with modified radical mastectomy (MRM) except for one case, in which ALND was performed. The histology reports of three patients that underwent MRM revealed no sign of intramammary adenocarcinoma. In two cases, there was history of contralateral breast cancer. Only one patient did not receive perioperative chemotherapy. The disease-free survival ranges between 6 months and 2 years. OBC presenting with axillary metastases is an unusual presentation, and there is not enough evidence to support recommendations regarding the management. For patients with no evidence of metastatic disease, the management can be individualized. There is vast heterogeneity in studies concerning the treatment of OBC.
Tài liệu tham khảo
citation_journal_title=Breast J; citation_title=Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases; citation_author=X Wang, Y Zhao, X Cao; citation_volume=16; citation_issue=1; citation_publication_date=2010; citation_pages=32-37; citation_doi=10.1111/j.1524-4741.2009.00848.x; citation_id=CR1
citation_journal_title=Cancer; citation_title=Breast carcinoma presenting as axillary metastases without evidence of a primary tumor; citation_author=M Merson, S Andreola, V Galimberti, R Bufalino, S Marchini, U Veronesi; citation_volume=70; citation_publication_date=1992; citation_pages=504-508; citation_doi=10.1002/1097-0142(19920715)70:2<504::AID-CNCR2820700221>3.0.CO;2-T; citation_id=CR2
citation_journal_title=Cancer; citation_title=Axillary lymph node metastasis from an occult breast cancer; citation_author=J Patel, T Nemoto, D Rosner, TL Dao, JW Pickren; citation_volume=47; citation_publication_date=1981; citation_pages=2923-2927; citation_doi=10.1002/1097-0142(19810615)47:12<2923::AID-CNCR2820471231>3.0.CO;2-N; citation_id=CR3
citation_journal_title=J Clin Oncol; citation_title=Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin; citation_author=JL Abbruzzese, MC Abbruzzese, R Lenzi, KR Hess, MN Raber; citation_volume=13; citation_publication_date=1995; citation_pages=2094-2103; citation_doi=10.1200/JCO.1995.13.8.2094; citation_id=CR4
citation_journal_title=Am J Surg; citation_title=Occult primary adenocarcinoma with axillary metastases; citation_author=MM Kemeny, DE Rivera, JJ Terz, JR Benfield; citation_volume=152; citation_publication_date=1986; citation_pages=43-47; citation_doi=10.1016/0002-9610(86)90135-2; citation_id=CR5
Bleicher RJ, Morrow M (2007) Inflammatory breast cancer still poorly characterized. The Danwood/Christofanilli article reviewed. Oncology:21679–21680
National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology, breast cancer v1.2016. J Natl Compr Canc Netw 14:3.
https://doi.org/10.6004/jnccn.2016.0037
Hessler LK, Molitoris JK, Rosenblatt PY et al (2017) Factors influencing management and outcome in patients with occult breast Cancer with axillary lymph node involvement: analysis of the National Cancer Database. Ann Surg Oncol 24(10):2907–2914
Kim BH, Kwon J, Kim K (2017) Evaluation of the benefit of radiotherapy in patients with occult breast cancer: a population-based analysis of the SEER database. Cancer Res Treat 50(2):551–561